CINECA IRIS Institutional Research Information System

BALDOVINO, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.248
EU - Europa 7.437
AS - Asia 6.300
SA - Sud America 1.438
Continente sconosciuto - Info sul continente non disponibili 717
AF - Africa 214
OC - Oceania 111
Totale 28.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.502
IT - Italia 2.691
CN - Cina 1.895
SG - Singapore 1.705
BR - Brasile 712
DE - Germania 682
FR - Francia 635
JP - Giappone 513
VN - Vietnam 497
ES - Italia 453
FI - Finlandia 437
GB - Regno Unito 410
IE - Irlanda 410
MX - Messico 382
SE - Svezia 310
IN - India 301
CA - Canada 265
CO - Colombia 243
KR - Corea 241
UA - Ucraina 220
TR - Turchia 174
HK - Hong Kong 172
PL - Polonia 160
AR - Argentina 159
ID - Indonesia 155
AT - Austria 130
NL - Olanda 126
RU - Federazione Russa 114
GR - Grecia 107
AU - Australia 99
CH - Svizzera 96
PT - Portogallo 91
BD - Bangladesh 89
CL - Cile 86
TW - Taiwan 81
PE - Perù 73
SA - Arabia Saudita 71
EC - Ecuador 67
TH - Thailandia 63
RO - Romania 60
BE - Belgio 59
IR - Iran 51
IL - Israele 48
VE - Venezuela 47
EG - Egitto 46
IQ - Iraq 37
PK - Pakistan 35
ZA - Sudafrica 32
CZ - Repubblica Ceca 30
RS - Serbia 29
SI - Slovenia 29
DZ - Algeria 27
PH - Filippine 27
DK - Danimarca 25
MA - Marocco 24
TN - Tunisia 23
NO - Norvegia 22
EU - Europa 21
CR - Costa Rica 20
AE - Emirati Arabi Uniti 19
MY - Malesia 19
UY - Uruguay 19
UZ - Uzbekistan 19
BG - Bulgaria 18
HU - Ungheria 18
JO - Giordania 18
PS - Palestinian Territory 17
PY - Paraguay 16
BO - Bolivia 15
LT - Lituania 15
NI - Nicaragua 15
NG - Nigeria 13
HR - Croazia 12
NZ - Nuova Zelanda 12
JM - Giamaica 11
AZ - Azerbaigian 9
GT - Guatemala 9
KE - Kenya 7
LB - Libano 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
BY - Bielorussia 6
LK - Sri Lanka 6
NP - Nepal 6
QA - Qatar 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BS - Bahamas 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
EE - Estonia 5
CM - Camerun 4
CU - Cuba 4
GH - Ghana 4
KZ - Kazakistan 4
MK - Macedonia 4
MT - Malta 4
PR - Porto Rico 4
RE - Reunion 4
Totale 27.704
Salva come PNG Salva come JPEG
Città #
Singapore 952
Ann Arbor 902
Beijing 709
Santa Clara 693
Chandler 544
Ashburn 536
Fairfield 501
San Jose 480
Dublin 390
Houston 382
Redwood City 380
Torino 361
Wilmington 335
Milan 292
Helsinki 248
Woodbridge 240
Seattle 219
Turin 197
Villeurbanne 173
Cambridge 161
Rome 160
Tokyo 159
Jacksonville 150
Los Angeles 143
Munich 143
The Dalles 141
Medford 138
Princeton 135
Ho Chi Minh City 125
Pisa 121
Hong Kong 117
Columbus 112
Warsaw 112
Dearborn 109
Hanoi 108
Lauterbourg 107
Nyköping 101
Shanghai 100
Guangzhou 99
Buffalo 95
São Paulo 90
Council Bluffs 85
New York 85
Dallas 84
Vienna 84
Lubbock 83
Bogotá 81
Dong Ket 77
Seoul 77
Madrid 75
Atlanta 73
Jakarta 70
Fremont 67
Nanjing 65
Hangzhou 64
Boston 61
Santiago 60
Medellín 57
Chicago 56
Barcelona 52
Mexico City 51
London 50
San Diego 49
Toronto 47
Lima 45
Paris 45
Buenos Aires 44
Istanbul 43
Hefei 42
Chengdu 41
Frankfurt am Main 41
Mumbai 41
Florence 38
Boardman 36
Taipei 36
Guadalajara 35
Naples 35
Osaka 33
Athens 32
Belo Horizonte 30
Montreal 30
Ottawa 29
Silver Spring 29
Bologna 27
Orem 27
Quito 27
Phoenix 26
Washington 26
Wuhan 26
Ankara 25
Bangkok 25
Changsha 25
Düsseldorf 25
Nuremberg 25
Zhengzhou 25
Mexico 24
Rio de Janeiro 24
Zapopan 24
Brussels 23
Norwalk 23
Totale 13.945
Salva come PNG Salva come JPEG
Nome #
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 1.335
Acute kidney injury associated with glomerular diseases 1.195
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.190
Antiphospholipid Syndrome and the Kidney 1.009
Value of colchicine as treatment for recurrent oral ulcers: a systematic review 796
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 696
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 644
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 633
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 623
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 619
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 606
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 538
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 515
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 510
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 504
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 478
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 397
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 394
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 394
Long-term evaluation of pemphigus vulgaris: a retrospective consideration of 98 patients treated in an oral medicine unit in North-West Italy 365
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 352
Upcoming biological therapies in systemic lupus erythematosus. 351
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 314
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 308
The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: a preliminary evaluation 282
Rituximab in cryoglobulinemic peripheral neuropathy 275
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 271
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 264
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 260
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 258
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 254
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 247
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 244
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 242
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 228
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 221
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 212
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance—A Patient-Driven, Multistep-Approach Study 211
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 211
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 208
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story 202
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 201
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy 201
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris 192
External Quality Assurance (EQA) of Immunofixation and serum free light chain measure in 9 laboratories participating in the Piedmont and Aosta Valley consortium for systemic amyloidosis 189
Extemporaneous orphan drugs and preparations for rare diseases: organisation and management of an inter-regional network 186
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 179
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 172
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 167
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy 165
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis 164
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 162
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 162
Short and long-term effects of Rituximab in the treatment of severe cryoglobulinaemia with and without glomerulonephritis 154
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 149
Association between hereditary angioedema and lupus erythematosus in the mother and the son 148
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 146
Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease 143
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 141
Anticorpo monoclonale anti CD20 nella crioglobulinemia mista 139
Effetti a lungo termine del rituximab nel trattamento delle forme più severe di crioglobulinemia mista HCV associata 139
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy 139
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 138
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso Sistemico 137
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 136
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 134
Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort 134
Immunological rare diseases 130
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease 130
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 128
Short and long term effects on Rituximab in the treatment of severe cryoglubulinaemia with and without glomerulonephritis 125
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 123
null 122
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso sistemico 121
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 120
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 119
Induction of remission by B lymphocyte depletion in patients with idiopathic systemic vasculitis 119
INTENSIFIED B LYMPHOCYTE DEPLETION (IBLD) WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE TREATMENT AS A RESCUE THERAPY IN REFRACTORY LUPUS NEPHRITIS (LN): A 4-YEAR OBSERVATION 113
Alterazioni videocapillaroscopiche nella crioglobulinemia mista ocn danno renale 112
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 112
Induction of remission by B lynfocyte depletion in patients with idiopathic systemic vasculitis 110
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 108
Immunogenetics of complement in mixed cryoglobulinaemia 105
Percorso gestionale standardizzato dalla prescrizione all'erogazione di galenici magistrali per pazienti affetti da malattie rare ed allestiti presso le farmacie ospedaliere di Piemonte e Valle d'Aosta 105
EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA 105
La crioglobulinemia mista 104
Long-term effects of Rituximab in the treatment of severe cryoglobluinaemia 104
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation 104
A global survey about undiagnosed rare diseases: perspectives, challenges, and solutions 103
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 103
Piedmont and Aosta Valley Consortium of Systemic Amyloidosis: results of a four year experience 101
Structural and functional properties of proteasomes purified from the human kidney 100
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 100
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App 99
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia 96
VERY LONG-TERM Effects Of The "4 PLUS2 Infusion PROTOCOL" Of Rituximabalone In Patients With HCV-Associatedmixed Cryoglobulinemia With Diffusemembranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcersof Skin 96
Nail fold capillaroscopy in mixed cryoglobulinaemia 95
Malattie Rare: la rete di segnalazione 94
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence 93
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 93
Totale 26.565
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.454
article - articoli 0
book - libri 0
conference - conferenze 11.762
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.880 0 163 201 295 321 286 326 273 221 178 277 339
2022/20232.496 252 194 89 175 177 524 205 221 257 113 165 124
2023/20241.791 230 224 141 134 178 132 127 114 41 134 132 204
2024/20253.657 88 206 211 309 815 291 201 239 402 223 258 414
2025/20267.035 429 269 360 621 502 385 842 334 511 500 1.258 1.024
2026/2027549 453 96 0 0 0 0 0 0 0 0 0 0
Totale 28.465